(54.236.58.220) 您好!臺灣時間:2021/03/09 16:51
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:蘇峻新
論文名稱:台中地區醫院呼吸照護病房生物氣膠之研究
論文名稱(外文):The research of the bioaerosol at the respiratory care ward in the hospital of Taichung region
指導教授:王俊欽王俊欽引用關係陳秀玲陳秀玲引用關係
學位類別:碩士
校院名稱:弘光科技大學
系所名稱:環境工程研究所
學門:工程學門
學類:環境工程學類
論文種類:學術論文
畢業學年度:99
語文別:中文
論文頁數:101
中文關鍵詞:安德森六階式採樣器生物氣膠細菌真菌
外文關鍵詞:andersen six-stage viable samplerbioaerosolbacteriafungi
相關次數:
  • 被引用被引用:1
  • 點閱點閱:270
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
存在醫院空氣中的生物氣膠主要來自院內活動之人們,醫護人員在診療病患過程中可能造成該區域生物氣膠濃度瞬間上昇,這些生物氣膠是否會傷害到醫護人員或隨院內之空調系統散播至它處,值得瞭解與探討。因此本研究採集台中地區三家醫院呼吸照護病房中之生物氣膠,以獲悉該環境之細菌與真菌的種類與數量,初步瞭解該些微生物是否會對醫護人員造成傷害。結果顯示醫院A呼吸照護病房中地點A-E(A地點位於洗澡間;B地點位於陽台;C地點位於辦公室;D及E地點位於病床區)之細菌與真菌平均濃度(cfu/m3)分別為1096±1105、880±802、788±1149、671±762、528±456及395±256、547±427、418±384、307±218、291±232。醫院B呼吸照護病房中地點A-E之細菌與真菌平均濃度(cfu/m3)分別為525±380、260±191、561±256、631±320、583±593及336±341、284±135、229±183、226±163、253±183。醫院C呼吸照護病房中地點A-E之細菌與真菌平均濃度(cfu/m3)分別為872±496、792±404、313±169、277±180、498±232及485±266、789±373、320±195、292±168、274±112。經菌種鑑定三家醫院存在較多細菌種類為Staphylococcus sp.、Bacillus sp.、Mycobacterium sp.與Dermacoccus sp.;較多真菌種類為Aspergillus sp.、Yarrowia sp.、Penicillium sp.及Paecilomyces sp.。此外,三家醫院利用五種採樣粒徑採集之不同大小生物氣膠中,以4.7-7.0m培養出來之細菌數量較多;真菌則以2.1-7.0m培養出來的數量較多。
Bioaerosols existing in the hospital come from the person's body. When the people stay a long time at the side of the patient that has the respiratory disease, the influence of the people's health are to be worth understanding. Therefore, the purpose of this study attempted to understand the concentration and types of the airborne microorganism at respiratory care ward in three hospitals of Taichung region. Besides, the aim is to understand the health effect of the people that stay a long time at the side of the patient with the bacteria and fungi concentrations. The results are: The total average bacteria and fungi concentration were 1096±1105, 880±802, 788±1149, 671±762, 528±456 and 395±256, 547±427, 418±384, 307±218, 291±232 cfu/m3 at sampling sites of A-E (A: washroom; B: balcony; C: office; D and E: sickbed) in the respiratory care ward of hospital A. The total average bacteria and fungi concentration were 525±380, 260±191, 561±256, 631±320, 583±593 and 336±341, 284±135, 229±183, 226±163, 253±183 cfu/m3 at sampling sites of A-E in the respiratory care ward of hospital B. The total average bacteria and fungi concentration were 872±496, 792±404, 313±169, 277±180, 498±232 and 485±266, 789±373, 320±195, 292±168, 274±112 cfu/m3 at sampling sites of A-E in the respiratory care ward of hospital C. The dominant bacteria and fungi types at respiratory care ward of three hospitals were Staphylococcus sp., Bacillus sp., Mycobacterium sp., Dermacoccus sp. and Aspergillus sp., Yarrowia sp., Penicillium sp., Paecilomyces sp. The particle sizes of 4.7-7.0 m and 2.1-7.0 m have the largest bacteria and fungi number at three hospitals.
中文摘要................................................................................................ Ⅰ
英文摘要................................................................................................ Ⅱ
目 錄.................................................................................................... Ⅲ
表 目 錄…………………………………………………………….. Ⅶ
圖 目 錄…………………………………………………………….. Ⅸ
第一章 緒論..................................................................................... 1
1-1 前言..................................................................................... 1
1-2 研究目的............................................................................. 2
第二章 文獻回顧……………………………………………….. 3
2-1 生物氣膠之基本特性…………………………………... 3
2-1-1 細菌特性…………………………………………... 4
2-1-2 真菌特性…………………………………………… 6
2-2 環境因子…………………………………………... 7
2-2-1 溫度………………………………………………… 7
2-2-2 相對溼度………………………………………....... 8
2-2-3 二氧化碳 (CO2)……………………………........... 8
2-3 生物氣膠對人體健康危害……………………….. 9
2-4 室內生物氣膠之粒徑分佈…………………………… 11
2-5 室內生物氣膠規範值………………………………………. 12
2-6 國內外學者對室內生物氣膠之相關研究............................. 13
第三章 實驗設備與方法……………………………………….. 18
3-1 採樣地點……………………………………………………. 18
3-1-1 A醫院…………………………………………………... 19
3-1-2 B醫院…………………………………………………... 23
3-1-3 C醫院…………………………………………………... 27
3-2 採樣時間…………………………………………………… 30
3-3 採樣高度…………………………………………………… 30
3-4 儀器及藥品………………………………………………… 31
3-4-1安德森六階生物氣膠採樣器………………………….. 31
3-4-2 溫濕度計………………………………………………. 32
3-4-3 CO2偵測器……………………………………………... 33
3-4-4 培養基…………………………………………………. 33
3-5 採樣流程…………………………………………………… 34
3-6 資料分析………………………………………………….... 35
3-6-1微生物平均濃度……………………………………….. 35
3-6-2菌種鑑定……………………………………………….. 35
3-7資料管理與統計分析……………………………………. 36
第四章 結果與討論……………………………………………. 37
4-1室內環境測量………………………………………………. 37
4-1-1溫度與相對溼度……………………………………….. 37
4-1-2二氧化碳濃度………………………………………….. 39
4-2生物氣膠濃度分佈………………………………………….. 40
4-2-1 A醫院…………………………………………………... 40
4-2-2 B醫院…………………………………………………... 45
4-2-3 C醫院…………………………………………………... 50
4- 3室內/室外值(I/O) ………………………………................... 56
4-4 菌種鑑定及分佈……………………………………............. 58
4-4-1 A醫院……………………………………………….. 58
4-4-2 B醫院……………………………………………….. 61
4-4-3 C醫院……………………………………………….. 64
4-5 粒徑分析…………………………………………………. 69
4-6 統計分析…………………………………………………. 74
4-6-1三間醫院中微生物濃度與環境因子的關係……….. .. 74
4-6-1-1 A醫院………………………………………………………… 74
4-6-1-2 B醫院…………………………………………. 76
4-6-1-3 C醫院................................................................. 77
4-6-2三間醫院環境因素與微生物組成分分析………… 79
4-6-2-1 A醫院……………………………………………………….. 79
4-6-2-2 B醫院………………………………………. 81
4-6-2-3 C醫院............................................................... 83
4-6-3 三間醫院秋冬兩季對細、真菌之差異…………… 87
4-6-3-1 A醫院………………………………………………………… 87
4-6-3-2 B醫院………………………………………. 89
4-6-3-3 C醫院............................................................... 91
第五章 結論與建議........................................................... 93
5-1 結論………………………………………………………… 93
5-2 建議……………………………………………………… 96
參考文獻………………………………………………………… 97
英文文獻…………………………………………………. 97
中文文獻…………………………………………………. 100

Anderson, K., Morris, G., Kennedy, H., Croll, J., Michie, J., Richardson, M. D., Gibson, B., “Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design and indoor air”. Thorax 1996; 51(3): 256-261.
American standard, Inc. (2002). Indoor air quality: a guide to understanding ASHRAE standard 62-2001.
Bush, R. K. and J. M. Portnoy (2001). The role and abatement of fungal allergens in allergic diseases. Journal of Allergy and Clinical Immunology
Burch, M., and Levetin, E. (2001). Effects of meteorological conditions on spore plumes. International Journal of Biometeorology, 46(3), 107-117.
Burge, H. A. and J. A. Otten. (1999). Fungi. In: Macher J, editor. Bioaerosols:Assessment and Control. Cincinnati, OH: American Conference of Governmental Industrial Hygienists (ACGIH) 19:1-13.
Burrell, R. (1991). Microbiological agents as health risks in indoor air. Environmental Health Perspectives, 95, 29-34.
Chad J. Roy, M.S.P.H.,Ph.D., and Donald K. Milton, M.D., Dr.P.H., “airborne trans-mission of Communicable Infection –The Elusive Pathway”,The New England Jour-nal of Medicine,350:17pp. 1710-1712 (2004)
Cole EC, Cook CE. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control 1998;26:453-64.

Gravesen, S., “Fungi as a cause of allergic disease”. Allergy 1979; 34: 135-154.
Mara Di Giulio.,Rossella Grande.,Emanuela Di Campli.,Soraya Di Bartolomeo.,Luigina Cellini, (2009). Indoor air quality in university environments, Environ Monit Assess (2010) 170:509–517
Husman, T., “Health effects of indoor-air microorganisms”. Scandinavian journal of work environment&health 1996; 22(1): 5-13.
Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., Stahlhofen, W. (1986). Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. Journal of Aerosol Science, 17(5), 811-825.
Hollins, P. D., Kettlewell, P. S., Atkinson, M. D., Stephenson, D. B., Corden, J. M., Millington, W. M., et al. (2004). Relationships between airborne fungal spore concentration of cladosporium and the summer climate at two sites in britain. International Journal of Biometeorology, 48(3), 137-141.
Jones, A. M., Harrison, R. M. (2004). The effects of meteorological factors on atmospheric bioaerosol concentrations - A review. Science of the Total Environment, 326(1-3), 151-180.
Li, C. S., Kuo, Y. M., “Airborne characterization of fungi indoors and outdoors”. Journal of Aerosol Science 1992; 23(1): 667-670.
Li, C.S. and L.U. Hsu (1997). Airborne fungus allergen in association withresidential characteristics in atopic and control children in a subtropical region.Archives of Environmental Health 52 :72-79.
Lee, J. H. and W. K. Jo (2006). Characteristics of indoor and outdoor bioaerosols atKorean high-rise apartment buildings. Environmental Research 101:11-17.
Lacey J. and J. Dutkiewicz (1994). Bioaerosols and occupational lung disease.Journal of Aerosol Science 25:1371-1404 .
L e g g i a d r o R J, S c h a b e r g DR. No s o c omi a l pneumococcal infection: an outbreak. Hosp Pract 1999;34:77-8, 81-2, 86-92.
Lin, W. H., Chen, Y. H., and Pai, J. Y. (2004). Bioaerosol Characteristics in a Hospital. The Chung Shan Medical Journal; 15(1): 97-108.
Mahieu, L. M., De Dooy, J. J., Van Laer, F. A., Jansens, H., and Leven, M. M.(2000). A Prospective Study on Factors Influencing Aspergillus Spore Load in the Air during Renovation Works in a Neonatal Intensive Care Unit. Journal of Hospital Infection, 45:191-197.
Nielsen, K. F., G. Holm, L. P .Uttrup and P. A. Nielsen (2004). Mould growth on building materials under low water activities. Influence of humidity and temperature on fungal growth and secondary metabolism. International Biodeterioration & Biodegradation 54:325-336.
Otten, J.A. and H.A. Burge. (1999). Bacteria. In Bioaerosols: Assessment and Control Ed.
Pasanen, A. L., S. Rautiala, J. P. Kasanen, P. Raunio, J. Rantamaki and P.Kalliokoski (2000). The relationship between measured moisture conditions and fungal concentrations in water-damaged building materials. Indoor Air 10:111-120.
Solley, G. O., Hyatt, R. E., “Hypersensitivity pneumonitis induced by Penicillium species”. Journal of allergy and clinical immunology 1980; 65(1): 65-70.
Sears C. A dynamic partnership: Celebrating our gut flora. Anaerobe. 2005, 11 (5): 247–51.
Stennett, P. J., and Beggs, P. J. (2004). Alternaria spores in the atmosphere of sydney, australia, and relationships with meteorological factors. International Journal of Biometeorology, 49(2), 98-105.
Tsai, Y. J., Gershwin, M. E., “The sick building syndrome: what is it when it is” Comprehensive Therapy 2002; 28: 140-144.
Troutt, C., and Levetin, E. (2001). Correlation of spring spore concentrations and meteorological conditions in tulsa, oklahoma. International Journal of Biometeorology, 45(2), 64-74.
Wu, P.C., Y. Y. Li, C. M. Chiang, C. Y. Huang, C. C. Lee, F. C. Li and H. J. Su(2005). Changing microbial concentrations are associated with ventilation performance in Taiwan's air-conditioned office buildings. Indoor Air 15:19-26.

中華民國建築學會(1986,3),「換氣與空氣調節設備技術規範」,內政部營建署。
方盈禎、趙 馨、吳欣橋、陳叡瑜,台北市長期照護機構空氣中細菌之分佈與特性,台灣衛誌 2010, Vol.29, No.3

台灣衛誌 2010;29(3):273-282
江哲銘,(1996),「建築技術規則有關通風條文增修訂之研究」,內政部建築研究所。
林文海、陳雅惠、白佳原,醫院之空氣中生物氣膠濃度,Chung shan Med J 15:97~107, 2004.
金煥宗、張怡塘 ,生物氣膠-民眾漠視的室內空氣污染源,水利土木科技資訊季刊-41 期 25~26, 2006.
涂玉峰,(1999),「室內空氣環境綜合評估指標之探討-以台灣南部工業區辦公大樓為例」,成功大學建築研究所碩士論文。
郭瑜欣,(2008),"南台灣某老人安養機構室內環境空中真菌之調查研究",碩士論文,國立台南大學。
黃麗玲、毛義方、陳美蓮、黃建財,某教學醫院室內空氣之微生物,台灣衛誌 2006, Vol.25, No.4 315-322.
翁芝琦,牙科診療間環境暴露調查與評估-VOCS及生物氣膠,高雄醫學大學健康科學公共衛生研究所碩士論文,高雄,2005.
張靜文,空氣中生物性危害與呼吸防護(下)。北市衛生1999;46:19-22。
李信緯,探討室內空氣品質與通風稀釋改善之研究,國立台北科技大學冷凍空調研究所碩士論文,台北,2007.

連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔